Plasma cell dyscrasias (PCDs), like multiple myeloma, are hematologic disorders that lead to compromised immune responses, making vaccinations, particularly against influenza, less effective in patients with PCDs due to their altered immunity and the impacts of antimyeloma therapies.
SHIVERING 2 Trial Shows Tandem High-Dose Influenza Vaccines Significantly Improve Protection in Plasma Cell Dyscrasia Patients
Tori Gustafson2024-04-15T15:47:36+00:00April 15th, 2024|multiple myeloma|Comments Off on SHIVERING 2 Trial Shows Tandem High-Dose Influenza Vaccines Significantly Improve Protection in Plasma Cell Dyscrasia Patients